Prophylactic Dendritic Cell Vaccination in Experimental Breast Cancer Controls Immunity and Hepatic Metastases
/in Breast Cancer, Dendritic Cells, International PublicationsA Bayesian network meta-analysis of comparison of cancer therapeutic vaccines for melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaInsights Into Dendritic Cells in Cancer Immunotherapy: From Bench to Clinical Applications
/in Dendritic Cells, International PublicationsCancer Vaccines for Genitourinary Tumors: Recent Progresses and Future Possibilities
/in Dendritic Cells, International Publications, Prostate Cancer, Urothelial CarcinomaA phase I study to evaluate the safety and effectiveness of neoantigen-based personalized dendritic cell vaccine in patients with advanced solid tumors.
/in Dendritic Cells, International PublicationsImmunotherapeutic Approaches in Malignant Pleural Mesothelioma
/in Dendritic Cells, International Publications, Malignant Pleural MesotheliomaRecent Progress in Dendritic Cell-Based Cancer Immunotherapy
/in Dendritic Cells, International PublicationsCD133 mRNA-transfected dendritic cells induce coordinated cytotoxic and helper T cell responses against breast cancer stem cells
/in Breast Cancer, Dendritic Cells, International PublicationsLong-Term Follow-Up of Mesothelioma Patients Treated with Dendritic Cell Therapy in Three Phase I/II Trials
/in Dendritic Cells, International Publications, Malignant Melanoma, Malignant Pleural Mesothelioma
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer